相关实验视频
Updated: Jan 18, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.2K
个人心脏:用于改善心血管疾病管理的计算模型
Nick van Osta1, Tim van Loon1, Joost Lumens2
1Department of Biomedical Engineering, CARIM Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Heart (British Cardiac Society)
|September 10, 2025
概括
计算模型正在通过整合患者数据来提供个性化的护理来彻底改变心血管医学. 这些工具提高了诊断,加深了对心脏病的理解,并使量身定制的治疗能够改善患者的治疗结果.
科学领域:
- 心血管医学 心血管医学
- 计算生物学 计算生物学
- 生物医学工程 生物医学工程
背景情况:
- 心血管疾病 (CVD) 是全球主要的健康负担.
- 标准化治疗方法往往无法解释个体患者的变化.
- 计算模型为个性化心血管护理提供了一条道路.
研究的目的:
- 审查心血管医学计算建模的演变.
- 探索诊断,机械洞察和精准医学中的应用.
- 突出数据驱动型和知识驱动型模型的互补作用.
主要方法:
- 关于计算心血管建模的当前文献的综述.
- 应用程序的分析,包括人工智能引导的测量,基于模型的诊断和数字双胞胎.
- 讨论基于知识和数据的建模方法.
主要成果:
- 计算模型正在从研究工具转变为临床决策支持系统.
- 应用包括增强诊断准确性和治疗测试的患者特定模拟.
- 数据驱动和知识驱动的模型都为心血管疾病管理提供了独特的优势.
结论:
- 计算模型对于推进个性化心血管护理具有重大潜力.
- 跨学科合作,务实设计和混合方法对于未来的发展至关重要.
- 需要解决验证,监管和临床整合方面的挑战.
相关概念视频
Cardiomyopathy V: Interprofessional Care
343
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
343
Cardiomyopathy III: Hypertrophic Cardiomyopathy
416
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Cardiomyopathy II: Dilated Cardiomyopathy
480
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Pathophysiology of Cardiac Performance
1.4K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.4K

